Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Cash & Current Investments (2013 - 2026)

Xencor (XNCR) posted quarterly Cash & Current Investments of $384.4 million for Q1 2026, up 334.1% year-over-year from $88.5 million in Q1 2025, and down 11.68% quarter-over-quarter from $435.2 million in Q4 2025.

Analysis

Xencor (XNCR) Cash & Current Investments (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Cash & Current Investments for 14 consecutive years, with $384.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 334.1% year-over-year to $384.4 million; the TTM figure through Mar 2026 stood at $384.4 million (up 334.1% YoY), while the FY2025 annual figure was $435.2 million, down 3.25% from the prior year.
  • Cash & Current Investments fell to $384.4 million in Q1 2026 per XNCR's latest filing, from $435.2 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $551.5 million in Q4 2023 and bottomed at $59.0 million in Q2 2024.
  • Historically, Cash & Current Investments has averaged $238.0 million across 5 years, with a median of $112.1 million in 2023.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments sank 79.54% — and 2025, when it soared 583.32%.
  • Xencor's Cash & Current Investments stood at $96.4 million in 2022, then soared by 472.27% to $551.5 million in 2023, then slipped by 18.43% to $449.8 million in 2024, then retreated by 3.25% to $435.2 million in 2025, then fell by 11.68% to $384.4 million in 2026.
  • Business Quant data shows XNCR's Cash & Current Investments at $384.4 million in Q1 2026, $435.2 million in Q4 2025, and $112.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Xencor 2.02 Bn 1.65 Bn - 377.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 377.82 Mn
Mar 31, 2026 384.38 Mn
Dec 31, 2025 435.23 Mn
Sep 30, 2025 386.78 Mn
Jun 30, 2025 403.43 Mn
Mar 31, 2025 420.70 Mn
Dec 31, 2024 449.85 Mn
Sep 30, 2024 464.07 Mn
Jun 30, 2024 480.14 Mn
Mar 31, 2024 491.40 Mn
Dec 31, 2023 551.52 Mn
Sep 30, 2023 465.56 Mn
Jun 30, 2023 511.38 Mn
Mar 31, 2023 548.32 Mn
Dec 31, 2022 580.63 Mn
Sep 30, 2022 568.05 Mn
Jun 30, 2022 485.03 Mn
Mar 31, 2022 356.33 Mn
Dec 31, 2021 297.25 Mn
Sep 30, 2021 240.62 Mn